Restart Life Sciences Statistics

Total Valuation

Restart Life Sciences has a market cap or net worth of CAD 1.19 million. The enterprise value is 1.23 million.

Market Cap	1.19M
Enterprise Value	1.23M

Important Dates

The next estimated earnings date is Wednesday, November 27, 2024.

Earnings Date	Nov 27, 2024
Ex-Dividend Date	n/a

Share Statistics

Restart Life Sciences has 29.66 million shares outstanding. The number of shares has increased by 2.14% in one year.

Current Share Class	n/a
Shares Outstanding	29.66M
Shares Change (YoY)	+2.14%
Shares Change (QoQ)	n/a
Owned by Insiders (%)	10.05%
Owned by Institutions (%)	2.06%
Float	26.68M

Valuation Ratios

PE Ratio	n/a
Forward PE	n/a
PS Ratio	n/a
PB Ratio	n/a
P/TBV Ratio	n/a
P/FCF Ratio	n/a
P/OCF Ratio	n/a
PEG Ratio	n/a

Financial Ratio History

Enterprise Valuation

EV / Earnings	-1.96
EV / Sales	n/a
EV / EBITDA	n/a
EV / EBIT	n/a
EV / FCF	n/a

Financial Position

The company has a current ratio of 0.02

Current Ratio	0.02
Quick Ratio	0.02
Debt / Equity	n/a
Debt / EBITDA	n/a
Debt / FCF	n/a
Interest Coverage	n/a

Financial Efficiency

Return on Equity (ROE)	n/a
Return on Assets (ROA)	-895.11%
Return on Capital (ROIC)	n/a
Revenue Per Employee	n/a
Profits Per Employee	n/a
Employee Count	n/a
Asset Turnover	n/a
Inventory Turnover	n/a

Taxes

Income Tax	n/a
Effective Tax Rate	n/a

Stock Price Statistics

The stock price has decreased by -70.00% in the last 52 weeks. The beta is 0.63, so Restart Life Sciences's price volatility has been lower than the market average.

Beta (5Y)	0.63
52-Week Price Change	-70.00%
50-Day Moving Average	0.04
200-Day Moving Average	0.08
Relative Strength Index (RSI)	54.39
Average Volume (20 Days)	22,800

Short Selling Information

Short Interest	n/a
Short Previous Month	n/a
Short % of Shares Out	n/a
Short % of Float	n/a
Short Ratio (days to cover)	n/a

Income Statement

Revenue	n/a
Gross Profit	n/a
Operating Income	-628,894
Pretax Income	-628,581
Net Income	-628,581
EBITDA	-626,268
EBIT	-628,894
Earnings Per Share (EPS)	-0.02

Full Income Statement

Balance Sheet

The company has 12,060 in cash and 60,000 in debt, giving a net cash position of -47,940 or -0.00 per share.

Cash & Cash Equivalents	12,060
Total Debt	60,000
Net Cash	-47,940
Net Cash Per Share	-0.00
Equity (Book Value)	-1.05M
Book Value Per Share	-0.04
Working Capital	-1.06M

Full Balance Sheet

Cash Flow

Operating Cash Flow	-65,382
Capital Expenditures	n/a
Free Cash Flow	n/a
FCF Per Share	n/a

Full Cash Flow Statement

Margins

Gross Margin	n/a
Operating Margin	n/a
Pretax Margin	n/a
Profit Margin	n/a
EBITDA Margin	n/a
EBIT Margin	n/a
FCF Margin	n/a

Dividends & Yields

Restart Life Sciences does not appear to pay any dividends at this time.

Dividend Per Share	n/a
Dividend Yield	n/a
Dividend Growth (YoY)	n/a
Years of Dividend Growth	n/a
Payout Ratio	n/a
Buyback Yield	-2.14%
Shareholder Yield	-2.14%
Earnings Yield	-53.23%
FCF Yield	n/a

Stock Splits

The last stock split was on November 8, 2024. It was a reverse split with a ratio of 0.2.

Last Split Date	Nov 8, 2024
Split Type	Reverse
Split Ratio	0.2

Scores

Altman Z-Score	n/a
Piotroski F-Score	n/a